|

Rezvilutamide Tablets Clinical Trials

2 actively recruiting trials

▲ +1 trial since July 2026

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1
  • Jiangsu HengRui Medicine Co., Ltd.1

Indications

  • Cancer2
  • Metastatic Hormone-sensitive Prostate Cancer (mHSPC)1
  • Prostate Cancer (Post Prostatectomy)1

Other2 trials

A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Phase 3
Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.